IDH2 and astrocytoma (excluding glioblastoma): While TP53 mutations are often shared across all tumor cells in IDH-mutant astrocytoma, TP53 mutations in IDH-wildtype astrocytomas are frequently unique to one or a few tumor subclones [107].